RecruitingNCT07043153

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Using Combination of Albumin to Globulin Ratio and Prognostic Nutritional Index Model for Predicting Disease Activity in Patients With Systemic Lupus Erythematosus

Sponsor

Sohag University

Enrollment

200 participants

Start Date

Aug 5, 2025

Study Type

OBSERVATIONAL

Conditions

Systemic Lupus Erythematosus Disease

Summary

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

· Age ≥ 18 years.
Both sexes.
Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls.

Exclusion Criteria8

Co-existing chronic inflammatory or autoimmune diseases.
Age <18 years
Malignancy.
Pregnancy or lactation.
Chronic liver or renal insufficiency.
Malignant hematologic diseases.
Active hepatitis.
Acute infection within the previous four weeks

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAlbumin to globulin ratio and prognostic nutritional index model

Measurement of albumin to globulin ratio and prognostic nutritional index in participants to assess disease activity in systemic lupus erythematosus patients

Locations(1)

Sohag University hospitals

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07043153